The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of "“The therapeutic potential of C-C chemokine receptor antagonists in nonalcoholic steatohepatitis”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2022 |
Stergios A. Polyzos, Irene Lambrinoudaki, Dimitrios G. Goulis. Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease, Hormones. 2022; 21: 375. https://doi.org/10.1007/s42000-022-00369-8 |
|
2 |
2023 |
Li-Li Ren, Xiao-Jun Li, Ting-Ting Duan, Zheng-Hai Li, Jun-Zheng Yang, Ya-Mei Zhang, Liang Zou, Hua Miao, Ying-Yong Zhao. Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities, Chemico-Biological Interactions. 2023; 369: 110289110289. https://doi.org/10.1016/j.cbi.2022.110289 |
|
3 |
2025 |
Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo. Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis, International Journal of Molecular Sciences. 2025; 26: 1778. https://doi.org/10.3390/ijms26041778 |
|
4 |
2023 |
Apostolis PAPAEFTHYMIOU, Michael DOULBERIS, Kyriaki KARAFYLLIDOU, Eleftherios CHATZIMICHAEL, Georgia DERETZI, Aristomenis K. EXADAKTYLOS, Fotios SAMPSONAS, Athanasios GELASAKIS, Spyros I. PAPAMICHOS, Georgios KOTRONIS, Dimitra GIALAMPRINOU, Elisabeth VARDAKA, Stergios A. POLYZOS, Jannis KOUNTOURAS. Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease, Minerva Endocrinology. 2023; 48: https://doi.org/10.23736/S2724-6507.21.03564-8 |
|
5 |
2022 |
Chang-E Yang, Yan-Ni Wang, Meng-Ru Hua, Hua Miao, Ying-Yong Zhao, Gang Cao. Aryl hydrocarbon receptor: From pathogenesis to therapeutic targets in aging-related tissue fibrosis, Ageing Research Reviews. 2022; 79: 101662101662. https://doi.org/10.1016/j.arr.2022.101662 |